International Peptide Laws

Peptide regulations vary significantly worldwide. This guide provides an overview of peptide laws by country and region, covering legal status, regulatory bodies, and import/export considerations.

Travel & Import Warning: Peptide legality varies dramatically between countries. What's legal in one country may be prohibited in another. Always research local laws before traveling with or shipping peptides internationally.

North America

🇺🇸 United States

Gray Area

FDA regulated. Unscheduled but controlled for human use. Research use permitted.

🇨🇦 Canada

Restricted

Health Canada oversight. Many peptides are Schedule F (prescription only).

🇲🇽 Mexico

Legal

Many peptides available OTC. COFEPRIS regulates but enforcement varies.

Europe

🇬🇧 United Kingdom

Restricted

MHRA regulated. Most peptides are POM (prescription only). Personal import limits.

🇪🇺 European Union

Restricted

EMA oversight. Member states implement. Generally prescription required.

🇩🇪 Germany

Restricted

BfArM regulated. Strict pharmaceutical laws. Research exemptions exist.

🇳🇱 Netherlands

Restricted

CBG oversight. Prescription required for most therapeutic peptides.

🇫🇷 France

Restricted

ANSM regulated. Strict prescription requirements.

🇪🇸 Spain

Restricted

AEMPS oversight. Prescription system similar to EU standard.

🇮🇹 Italy

Restricted

AIFA regulated. Standard EU prescription framework.

🇵🇱 Poland

Gray Area

Emerging market. Regulations developing.

🇨🇭 Switzerland

Restricted

Swissmedic oversight. Not EU member but similar standards.

Asia-Pacific

🇦🇺 Australia

Restricted

TGA regulated. Most peptides Schedule 4. Strict import controls.

🇳🇿 New Zealand

Restricted

Medsafe oversight. Similar to Australia. Prescription required.

🇯🇵 Japan

Restricted

PMDA regulated. Strict pharmaceutical laws. Import restrictions.

🇰🇷 South Korea

Restricted

MFDS oversight. Generally prescription required.

🇨🇳 China

Gray Area

NMPA regulated. Major peptide manufacturer. Complex domestic rules.

🇮🇳 India

Gray Area

CDSCO oversight. Manufacturing hub. Variable domestic enforcement.

🇹🇭 Thailand

Gray Area

Thai FDA regulates. Wellness tourism market. Variable enforcement.

🇸🇬 Singapore

Restricted

HSA regulated. Strict import controls.

South America

🇧🇷 Brazil

Restricted

ANVISA regulated. Prescription required for most peptides.

🇦🇷 Argentina

Gray Area

ANMAT oversight. Variable enforcement.

🇨🇴 Colombia

Gray Area

INVIMA regulates. Developing framework.

Middle East

🇦🇪 UAE

Restricted

MOH regulated. Strict import rules. Dubai has specific regulations.

🇮🇱 Israel

Restricted

MOH oversight. Prescription required for therapeutic peptides.

🇸🇦 Saudi Arabia

Restricted

SFDA regulated. Strict import controls.

International Import/Export Considerations

General Principles

Customs declarations: Most countries require accurate customs declarations for pharmaceutical products
Personal use exemptions: Some countries allow limited personal imports, others do not
Documentation: Prescriptions or research documentation may facilitate customs clearance
Prohibited substances: Some peptides may be classified as controlled substances in certain countries

High-Risk Jurisdictions

Countries with particularly strict enforcement include:

Australia - strict TGA enforcement, significant import controls
UAE - strict customs inspection, severe penalties
Japan - extensive import documentation required
Singapore - strict pharmaceutical controls

Regulatory Bodies by Region

North America: FDA (US), Health Canada, COFEPRIS (Mexico)
Europe: EMA (EU-wide), MHRA (UK), BfArM (Germany)
Asia-Pacific: TGA (Australia), PMDA (Japan), NMPA (China)
South America: ANVISA (Brazil), ANMAT (Argentina)

View All Laws